Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...
Cloner le dépôt, créer l’environnement, générer les données parquet, lancer le pipeline et exécuter les tests : ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback